Computational Screening of Heterocyclic L-Type Calcium Channel Blockers for Potential Anti-Parkinson’s Activity
Treating cardiovascular disorders like hypertension, arrhythmias, angina pectoris, and congestive heart failure involves using calcium channel blockers that bind allosterically to Cave L-type channels in myocytes in cardiac muscle. The heterocyclic compounds like 1, 4 dihydropyridines, phenyl a...
Saved in:
Main Authors: | Thomas Kurian, Rani Sebastian |
---|---|
Format: | Article |
Language: | English |
Published: |
Krupanidhi College of Pharmacy
2025-03-01
|
Series: | Journal of Pharmaceutical Research |
Online Access: | https://jopcr.com/articles/computational-screening-of-heterocyclic-l-type-calcium-channel-blockers-for-potential-anti-parkinsons-activity |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Docking Study of Heterocyclic Compounds for Antifungal Activity Against Granulomatous Amoebic Encephalitis
by: Thomas Kurian, et al.
Published: (2024-11-01) -
Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders
by: Aarish Manzar, et al.
Published: (2025-07-01) -
L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure
by: Gary S. Bird, et al.
Published: (2025-12-01) -
Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01) -
THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)